Swiss National Bank
TBIO

Swiss National Bank’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Swiss National Bank’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-98,300
Closed -$2.71M – 2627
2021
Q2 		$2.71M Sell
98,300
-3,600
-4% -$70.7K ﹤0.01% 1908
2021
Q1 		$1.68M Buy
101,900
+1,200
+1% +$27.3K ﹤0.01% 2107
2020
Q4 		$1.86M Buy
100,700
+7,400
+8% +$132K ﹤0.01% 1945
2020
Q3 		$1.27M Buy
93,300
+1,400
+2% +$21.6K ﹤0.01% 1954
2020
Q2 		$1.65M Buy
91,900
+51,700
+129% +$780K ﹤0.01% 1822
2020
Q1 		$401K Hold
40,200
– – ﹤0.01% 2262
2019
Q4 		$327K Buy
+40,200
New +$371K ﹤0.01% 2475

Swiss National Bank's TBIO Position: Q3 2021 in Review

Swiss National Bank sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 98,300 shares — an estimated $2.71M sold.

Swiss National Bank first reported a position in TBIO in Q4 2019 and held it in 7 quarters. The position peaked at $2.71M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Swiss National Bank reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Swiss National Bank sold 98,300 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.71M.
  • Swiss National Bank first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Swiss National Bank's Translate Bio, Inc. Common Stock position peaked at $2.71M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Swiss National Bank's 13F filing for Q3 2021, filed 8 Nov 2021.